Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00675363 · ClinicalTrials.gov registry record · NA
Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol.
A NA study of Critical Illness, sponsored by Mount Sinai Hospital, Canada.
- Completed
- Registry status
- NA
- Development phase
- 410
- Enrollment target
- 16
- Study locations
NCT00675363: Completed NA study of Critical Illness, sponsored by Mount Sinai Hospital, Canada.
NCT00675363 is a NA study of Critical Illness that has completed, run by Mount Sinai Hospital, Canada. The registered enrollment target is 410 participants, below the 3,134-participant average among 91 other Critical Illness trials with a reported enrollment target (87% lower). The trial reports 16 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00675363, a NA study of Critical Illness, has completed, sponsored by Mount Sinai Hospital, Canada.
- COMPLETED
- Registry status
- NA
- Development phase
- 410 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to determine whether the use of both a nurse-driven sedation protocol and daily sedative interruption, compared with a sedation protocol alone, result in better outcomes for mechanically ventilated adults.
Conditions Studied
Interventions
- PROCEDURE Protocolized Sedation
- PROCEDURE Protocolized sedation, with daily interruption
Study Locations (16)
Ontario
- Hamilton Health Sciences - Hamilton
- St. Joesph's Healthcare - Hamilton
- Sunnybrook HSC - Toronto
- St. Michael's Hospital - Toronto
- Mount Sinai Hospital - Toronto
- Toronto General Hospital - Toronto
- Toronto Western Hospital - Toronto
British Columbia
- Royal Columbian Hospital - New Westminster
- Surrey Memorial Hospital - Vancouver
- Providence Health Care-St. Paul's Hospital - Vancouver
Alberta
- Royal Alexandra Hospital - Edmonton
- Walter C. Mackenzie Health Sciences Centre - Edmonton
California
- Long Beach Memorial Medical Center - Long Beach
Massachusetts
- Tuft's Medical Centre - Boston
Manitoba
- Winnipeg Health Sciences Centre - Winnipeg
Quebec
- Maisonneuve Rosemount - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-10-17 |
| Phase | NA |
What the finished NCT00675363 record still lists
NCT00675363 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 3,134-participant average among 91 other Critical Illness trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Protocolized Sedation is the first listed.
NCT00675363 lists 16 locations in 7 states (Ontario, British Columbia, Alberta).
Frequently Asked Questions
What is clinical trial NCT00675363 about?
NCT00675363 is a clinical study titled "Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol.". The purpose of this study is to determine whether the use of both a nurse-driven sedation protocol and daily sedative interruption, compared with a sedation protocol alone, result in better outcomes for mechanically ventilated adults.
What is the current status of trial NCT00675363?
This trial is currently completed. It is a NA study. The enrollment target is 410 participants. The study started on 2008-01. Estimated completion is 2012-10-17.
What conditions does trial NCT00675363 study?
This clinical trial studies the following conditions: Critical Illness.
What interventions are being tested in trial NCT00675363?
The interventions under investigation include: Protocolized Sedation (PROCEDURE), Protocolized sedation, with daily interruption (PROCEDURE).
Who is sponsoring clinical trial NCT00675363?
This trial is sponsored by Mount Sinai Hospital, Canada, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00675363 being conducted?
This trial has 16 study locations across California, Massachusetts, Alberta, British Columbia, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00675363's enrollment target sits among peer trials
410 33rd of 91 higher than 59 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
-
PUSH-IT Continuing Enteral Feeds for Tracheostomy
RECRUITING · NA
-
Reestablishing Sleep and Circadian Alignment in Medical Intensive Care Unit (MICU) Patients Via a Mechanistic RCT of an Sleep Chronobundle
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia